Correlation Between Pfizer and WisdomTree CBOE
Can any of the company-specific risk be diversified away by investing in both Pfizer and WisdomTree CBOE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and WisdomTree CBOE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and WisdomTree CBOE SP, you can compare the effects of market volatilities on Pfizer and WisdomTree CBOE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of WisdomTree CBOE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and WisdomTree CBOE.
Diversification Opportunities for Pfizer and WisdomTree CBOE
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and WisdomTree is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and WisdomTree CBOE SP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WisdomTree CBOE SP and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with WisdomTree CBOE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WisdomTree CBOE SP has no effect on the direction of Pfizer i.e., Pfizer and WisdomTree CBOE go up and down completely randomly.
Pair Corralation between Pfizer and WisdomTree CBOE
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the WisdomTree CBOE. In addition to that, Pfizer is 2.49 times more volatile than WisdomTree CBOE SP. It trades about -0.07 of its total potential returns per unit of risk. WisdomTree CBOE SP is currently generating about 0.11 per unit of volatility. If you would invest 2,515 in WisdomTree CBOE SP on August 24, 2024 and sell it today you would earn a total of 880.00 from holding WisdomTree CBOE SP or generate 34.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. WisdomTree CBOE SP
Performance |
| Timeline |
| Pfizer Inc |
| WisdomTree CBOE SP |
Pfizer and WisdomTree CBOE Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and WisdomTree CBOE
The main advantage of trading using opposite Pfizer and WisdomTree CBOE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, WisdomTree CBOE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WisdomTree CBOE will offset losses from the drop in WisdomTree CBOE's long position.| Pfizer vs. Merck Company | Pfizer vs. Johnson Johnson | Pfizer vs. Eshallgo Class A | Pfizer vs. Amtech Systems |
| WisdomTree CBOE vs. Global X SP | WisdomTree CBOE vs. Global X Nasdaq | WisdomTree CBOE vs. First Trust BuyWrite | WisdomTree CBOE vs. Amplify CWP Enhanced |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |